PMC1242217_01
PMC1242217_02
PMC1242217_03
The patient experienced a substantial reduction in symptoms after receiving VNS therapy, as indicated by HRSD28 and MADRS scores. VNS therapy was initiated on March 17, 1999. The patient reported her pregnancy on May 30, 2002, and delivered a healthy child on January 24, 2003; remission of depression was sustained during the pregnancy.
1744-859X-4-16-1.jpg
PMC1242217_05_1744-859X-4-16-1.jpg
F1
She remained in clinical remission of depression throughout her pregnancy (Figures 1 through 3).
The patient's score on the CGI-S scale also indicated a substantial improvement after the initiation of VNS therapy. Pregnancy from May 30, 2002 to January 24, 2003 did not significantly affect the patient's CGI scores.
1744-859X-4-16-2.jpg
PMC1242217_05_1744-859X-4-16-2.jpg
F2
She remained in clinical remission of depression throughout her pregnancy (Figures 1 through 3).
Improvement in functioning is demonstrated by increases in GAF scores, beginning shortly after the start of VNS therapy and continuing through her pregnancy and delivery.
1744-859X-4-16-3.jpg
PMC1242217_05_1744-859X-4-16-3.jpg
F3
She remained in clinical remission of depression throughout her pregnancy (Figures 1 through 3).
PMC1242217_04
PMC1242217_05
The patient experienced a substantial reduction in symptoms after receiving VNS therapy, as indicated by HRSD28 and MADRS scores. VNS therapy was initiated on March 17, 1999. The patient reported her pregnancy on May 30, 2002, and delivered a healthy child on January 24, 2003; remission of depression was sustained during the pregnancy.
1744-859X-4-16-1.jpg
PMC1242217_05_1744-859X-4-16-1.jpg
F1
She remained in clinical remission of depression throughout her pregnancy (Figures 1 through 3).
The patient's score on the CGI-S scale also indicated a substantial improvement after the initiation of VNS therapy. Pregnancy from May 30, 2002 to January 24, 2003 did not significantly affect the patient's CGI scores.
1744-859X-4-16-2.jpg
PMC1242217_05_1744-859X-4-16-2.jpg
F2
She remained in clinical remission of depression throughout her pregnancy (Figures 1 through 3).
Improvement in functioning is demonstrated by increases in GAF scores, beginning shortly after the start of VNS therapy and continuing through her pregnancy and delivery.
1744-859X-4-16-3.jpg
PMC1242217_05_1744-859X-4-16-3.jpg
F3
She remained in clinical remission of depression throughout her pregnancy (Figures 1 through 3).
PMC1242217_06
PMC1242217_07
PMC1242217_08
PMC1242217_09